Brockville, ON – (October 9, 2013) newterra, a global leader in designing and manufacturing modular water treatment systems, has successfully completed a growth equity investment round led by current investor XPV Capital with additional growth equity capital provided by new investors led by Angeleno Group and joined by RobecoSAM, Ontario Venture Capital Fund, Black Coral Capital, and West Investments. The funding will accelerate newterra’s ongoing expansion to meet global demand for its advanced water treatment technology, highlighted by its proprietary, modular Membrane Bioreactor (MBR) and MicroClear™ flat-sheet membrane. It will also support expansion, hiring and research & development at the newterra Centre of Excellence for Advanced Water Treatment.
“I’m extremely pleased to announce that we have closed an equity financing with our partner, XPV Capital, and a group of new investors from Canada, the U.S. and Europe,” stated Bruce Lounsbury, Chief Executive Officer of newterra. “This new capital is a tremendous endorsement of our proprietary technology and unique, modular approach to the advanced water treatment market.”